Trial
NCT00742157
Evaluate the Efficacy and Safety Growth Hormone, Glutamine and Diet in Patients With Short Bowel Syndrome (SBS)
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Nebraska
Collaborators
Eli Lilly and Company
Condition
Short Bowel Syndrome
Intervention
Growth Hormone
Why stopped
Lack of Enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-09-08